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DialkylphosphitesAbstract Synthesis of a-aminophosphonates by a three-component condensation of an aldehyde,
amines and dialkyl phosphites in the presence of a non-ionic surfactant Triton X-100 catalyst at
70 C in aqueous medium is accomplished. The advantages are high yield, mild reaction conditions,
simple work-up and eco-friendliness. All the newly-synthesized compounds (4a–j) exhibited moder-
ate in vitro antibacterial and antifungal activities.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The synthesis of a-amino phosphonates has attracted much
attention recentlydue to their structural analogy toa-aminoacids
(Naydenova et al., 2010) and signiﬁcant biological activities.
They act as peptide mimics (Fields, 1999), enzyme inhibitors (Al-
len et al., 1989; Giannousis and Bartlett, 1987), antibiotics and
pharmacological agents (Atherton et al., 1986). As a result differ-
ent methods have been developed for the synthesis of a-amino
phosphonates (Romanenko and Kukhar, 2006; Ordonez et al.,
2009; Thirumurugan et al., 2010). Among them, the Kabach-nik–Fields reaction appears to be still one of the simplest and
most direct approaches (Tillu et al., 2011; Chandrasekhar et al.,
2001). This reaction proceeds via an imine formed by the reaction
of carbonyl compounds and amines, where it is converted to the
corresponding aminophosphonates by phosphite addition. This
one-pot reaction can be promoted by acid or base catalysts,
microwave irradiation or by heating (Ranu and Hajra, 2002).
Several acid catalysts, such as Lewis acids, examples are BiCl3
(Zhan and Li, 2005), FeCl3 (Rezaei et al., 2009), YbCl3 (Xu
et al., 2006), Al(OTf3) (Sobhani and Tashriﬁ, 2009), CAN
(Kasthuraiah et al., 2007), SbCl3/Al2O3 (Ambica et al., 2008)
and Brønsted acids, examples are sulfamic acid (Mitragotri
et al., 2008), oxalic acid (Vahdat et al., 2008), heteropoly acids
(Heydari et al., 2007), solid acids montmorillonite KSF (Yadav
et al., 2001), silica sulfuric acid (Yang et al., 2009), and Amber-
lite-IR 120 (Bhattacharya and Rana, 2008) and base catalysts,
such as CaCl2 (Kaboudin and Zahedi, 2008) and PPh3 (Tian
et al., 2009), as well as other catalysts, such as ZnO (Kassaee
et al., 2009), TiO2 (Hosseini-Sarvari, 2008), tosylchloride
(Kaboudin and Jafari, 2008), phenyltrimethylammoniumchlo-
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mide (Kudrimoti and Rao Bommena, 2005), tetramethyl-tetra-
3,4-pyridinoporphyrazinato copper(II) methyl sulfate [Cu(3,4-
tmtppa)(MeSO4)4] (Sobhani et al., 2008), tetra-tert-butylphthalo
cyanine (Matveeva et al., 2003), b-cyclodextrine (b-CD) (Kabou
din andSorbiun, 2007) andNBS (Wuet al., 2006), have been used
to promote this reaction.However, all the reportedmethods have
drawbacks, such as the long reaction time, unsatisfactory yields,
difﬁcult operations and environmental pollution caused by toxic
reagents and organic solvents. Owing to the importance of
a-aminophosphonates from pharmaceutical, industrial and syn-
thetic points of view, there is a great demand for the development
of more convenient, practical and efﬁcient method for their
synthesis.
In continuation of our work on the synthesis of various
biologically important compounds, we report here a highly
efﬁcient procedure for the preparation of a-aminophosphonate
and its derivatives via one-pot three component Kabachnik–
Fields reaction using non-ionic surfactant catalyst Triton
X-100 (5 mol%) in aqueous media. Even though Lewis and
Bronsted acid surfactant catalyzed reactions are reported for
them, there are very few reports involving non-ionic surfac-
tants as catalyst (Bhattacharya et al., 2003). The non-ionic
surfactant Triton X-100 (TR) is one of the most commonly
used detergents in biochemistry as solubilizer with a wide
range of applications to biological systems (Jones, 1999).
Solubilization of lipid membranes triggered by Triton X-100
is a well-described phenomenon. It is also used as an emulsi-
ﬁer, and complexing agent in both aqueous and non-aqueous
media.
In this communication, we report three component conden-
sation of piperanal, amine/substituted amines and diet-
hylphosphite/dimethylphosphite in water in the presence of
Triton X-100 (5 mol%). This reaction led to the formation
of diethyl/dimethyl benzo[d][1,3]dioxol-5-yl (phenylami-
no)methylphosphonate derivatives in good yields (Scheme 1).
2. Experimental
2.1. General
Melting points were recorded on Buchi R-535 apparatus and
are uncorrected. IR spectra were recorded on a Perkin–Elmer
683 spectrophotometer using KBr optics. 1H, 13C and 31P
NMR spectra were recorded on Bruker avance 500 MHz
NMR spectrometer operating at 500 MHz for 1H NMR,
125 MHz for 13C and 202 MHz for 31P NMR. NMR data re-
corded in CDCl3 were referenced to TMS (
1H and 13C) and
85% H3PO4 (
31P). Mass spectra were recorded on a JEOL
GCMATE II GC–MS spectrometer at SAIF, IIT, Chennai.
Elemental analyses were performed using a Perkin–ElmerScheme 1 Synthesis of a-aminophosp2400 instrument at the Central Drug Research Institute
(CDRI), Lucknow, India. All chemicals were purchased from
Sigma–Aldrich and were used with out further puriﬁcation.
Double distilled water was used as solvent.
2.2. Chemistry
2.2.1. General procedure for the synthesis of diethyl/dimethyl
benzo[d][1,3]dioxol-5-yl(phenylamino) methylphosphonate
derivatives (4a–j)
In a typical experiment piperanal (1.0 mmol), the respective
aniline (1.0 mmol) and the respective phosphite (1.0 mmol)
were taken in a mixture of Triton X-100 (5 mol%) and water
(2 mL) in a round bottomed ﬂask. The resulting mixture was
vigorously stirred at 70 C until completion of the reaction
as monitored by thin-layer chromatography (TLC). After
completion of reaction the mixture was extracted with ethyl
acetate, the aqueous phase was back extracted with ethyl ace-
tate (3 · 15 mL). The combined organic layers were dried over
anhydrous Na2SO4, ﬁltered. The ﬁltrate was evaporated under
reduced pressure. The resulting product was puriﬁed by col-
umn chromatography on silica gel (60–120 mesh, ethylace-
tate/hexane, 1:2) to afford pure products. Structures of the
all the products were conﬁrmed by analytical and spectral
data.
2.2.1.1. Diethyl benzo[d][1,3]dioxol-5-yl(phenylamino)meth-
ylphosphonate (4a). Solid, yield 82%,mp128–129 C; IR(KBr):
mmax = 3230 (N–H), 1232 (P‚O), 1015 (P–O–C), 750 (P–C) cm
1; 1H NMR (500 MHz, CDCl3): d= 7.34–6.50 (m, 8Ar-H),
6.92 (s, 1H, NH), 5.80 (s, 2H, OCH2O), 4.59 (d, J = 25.0 Hz,
1H, P–CH), 4.15–3.92 (m, 4H, 2 · P(O)CH2), 1.31–1.26 (t,
J = 7 Hz, 6H, 2 · P(O)CH2CH3); 13C NMR (125 MHz,
CDCl3): 148.2 (C-5), 147.2 (C-1
1), 145.2 (C-9), 129.3 (C-3),
126.5 (C-31 & C-51), 114.6 (C-21 & C-61), 126.5 (C-31 & C-51),
124.2 (C-41), 121.3 (C-11), 115.5 (C-10), 110.2 (C-4), 101.2
(C-7), 63.4 (d, J= 7.0 Hz, P(O)CH2), 63.3 (d, J= 6.6 Hz,
P(O)CH2), 55.7 (d, J= 152.4 Hz, C-2), 16.4 (d, J= 5.9 Hz,
P(O)CH2CH3), 16.2 (d, J= 5.5 Hz, P(O)CH2CH3);
31P
NMR(CDCl3): d= 22.20; GC–MS m/z (%): 363 (M
, 100).
Anal. Calc. for C18H22NO5P: C,59.50; H, 6.10; N, 3.85. Found:
C, 59.51; H, 6.09; N, 3.83.
2.2.1.2. Diethylbenzo[d][1,3]dioxol-5-yl(4-chlorophenylamino)
methylphosphonate (4b). Solid, yield 84%, mp 115–116 C;
IR(KBr): mmax = 3292 (N–H), 1234 (P‚O), 1015 (P–O–C), 752
(P–C) cm1; 1H NMR (500 MHz, CDCl3): d= 7.05–6.50
(m, 7Ar-H), 6.76 (s, 1H, NH), 5.83 (s, 2H, OCH2O), 4.59
(d, J = 25.0 Hz, 1H, P–CH), 4.17–3.94 (m, 4H, 2 · P(O)CH2),
1.31–1.28 (t, J = 7 Hz, 6H, 2 · P(O)CH2CH3); 13C
NMR(125 MHz, CDCl3): d= 148.0 (C-5), 145.3 (C-9), 145.2honates catalyzed by Triton X-100.
Triton X-100 catalyzed synthesis of a-aminophosphonates S687(C-11), 131.8 (C-21&C-61), 129.1 (C-3), 126.5 (C-31&C-51), 124.2
(C-41), 121.3 (C-11), 115.5 (C-10), 110.2 (C-4), 101.2 (C-7), 63.4
(d, J= 7.0 Hz, P(O)CH2), 63.3 (d, J= 7.0 Hz, P(O)CH2), 55.8
(d, J= 152.4 Hz, C-2), 16.4 (d, J= 5.6 Hz, P(O)CH2CH3),
16.2 (d, J= 5.7 Hz, P(O)CH2CH3);
31P NMR(CDCl3):
d= 22.35; GC–MS m/z (%): 397 (M, 100). Anal. Calc. for
C18H21ClNO5P: C, 54.35; H, 5.32; N, 3.52. Found: C, 54.32; H,
5.30; N, 3.50.2.2.1.3. Diethyl benzo[d][1,3]dioxol-5-yl(4-bromophenylamino)
methylphosphonate (4c). Solid, yield 83%, mp 135–136 C;
IR(KBr): mmax = 3296 (N–H), 1235 (P‚O), 1017 (P–O–C),
751 (P–C) cm1; 1H NMR(500 MHz, CDCl3): d= 7.19–6.46
(m, 7Ar-H), 6.12 (s, 1H, NH), 5.93 (s, 2H, OCH2O), 4.59 (d,
J = 24.0 Hz, 1H, P–CH), 4.16–3.94 (m, 4H, 2 · P(O)CH2),
1.31–1.15 (t, J = 7 Hz, 6H, 2 · P(O)CH2CH3); 13C
NMR(125 MHz, CDCl3): d= 148.2 (C-1
1), 148.0 (C-5), 147.4
(C-9), 144.7 (C-31 & C-51), 129.2 (C-3), 123.1 (C-21 & C-61),
121.3 (C-10), 121.2 (C-11), 115.3 (C-4), 115.0 (C-41), 101.2
(C-7), 63.4 (d, J= 6.9 Hz, P(O)CH2), 63.2 (d, J= 7.0 Hz,
P(O)CH2), 56.4 (d, J= 150.0 Hz, C-2), 16.3 (d, J= 5.7 Hz,
P(O)CH2CH3), 16.2 (d, J= 5.4 Hz, P(O)CH2CH3);
31P
NMR(CDCl3): d= 22.25; GC–MS m/z (%): 442 (M
, 100).
Anal. Calc. for C18H21BrNO5P: C, 48.89; H, 4.79; N, 3.17.
Found: C, 48.85; H, 4.76; N, 3.15.
2.2.1.4. Diethylbenzo[d][1,3]dioxol-5-yl(3-chloro-4-ﬂuorophe-
nylamino) methylphosphonate (4d). Solid, yield 79%, mp 130–
132 C; IR(KBr): mmax = 3319 (N–H), 1232 (P‚O), 1023
(P–O–C), 754 (P–C)cm1; 1H NMR(500 MHz, CDCl3):
d= 7.20–6.95 (m, 6Ar-H), 6.56 (s, 1H, NH), 5.82 (s, 2H,
OCH2O), 4.60 (d, J = 25.0 Hz, 1H, P–CH), 4.16–3.89 (m, 4H,
2 · P(O)CH2), 1.31–1.19 (t, J = 7 Hz, 6H, 2 · P(O)CH2CH3);
13C NMR(125 MHz, CDCl3): 147.5 (C-5), 145.6 (C-1
1), 144.9
(C-9), 128.3 (C-3), 124.2 (C-41), 120.4 (C-11), 119.8 (C-31),
116.0 (C-61), 114.9 (C-21), 113.9 (C-51), 112.8 (C-10), 112.6
(C-4), 101.5 (C-7), 63.2 (d, J= 6.8 Hz, P(O)CH2), 63.1
(d, J= 7.0 Hz, P(O)CH2), 60.5 (d, J= 151.2 Hz, C-2), 16.4 (d,
J= 5.5 Hz, P(O)CH2CH3), 16.2 (d, J= 5.7 Hz, P(O)CH2CH3);
31P NMR(CDCl3): d= 22.32; GC–MS m/z (%): 415 (M
, 100).
Anal. Calc. for C18H21ClFNO5P: C, 52.00; H, 4.85; N, 3.37.
Found: C, 51.09; H, 4.84; N, 3.35.2.2.1.5. Diethyl benzo[d][1,3]dioxol-5-yl(4-methoxyphenyl-
amino)methylphosphonate (4e). Solid, yield 86%, mp 126–
127 C; IR(KBr): mmax = 3320 (N–H), 1238 (P‚O), 1017
(P–O–C), 753 (P–C) cm1; 1H NMR(500 MHz, CDCl3):
d= 7.20–6.58 (m, 7Ar-H), 6.64 (s, 1H, NH), 5.80 (s, 2H,
OCH2O), 4.58 (d, J = 25.2 Hz, 1H, P–CH), 4.15–3.84
(m, 4H, 2 · P(O)CH2), 2.54 (s, 3H, OCH3), 1.30–1.26 (t, J =
7 Hz, 6H, 2 · P(O)CH2CH3); 13C NMR(125 MHz, CDCl3):
150.6 (C-41), 148.9 (C-5), 146.8 (C-9), 140.1 (C-11),129.7
(C-3), 120.5 (C-11), 117.2 (C-31 & C-51), 115.6 (C-21 &
C-61), 112.8 (C-10), 112.5 (C-4), 101.4 (C-7), 64.5 (d,
J= 7.0 Hz, P(O)CH2), 64.3 (d, J= 7.0 Hz, P(O)CH2), 60.5
(d, J= 152.0 Hz, C-2), 56.8 (Ar-OCH3), 16.3 (d, J= 5.5 Hz,
P(O)CH2CH3), 16.2 (d, J= 5.4 Hz, P(O)CH2CH3);
31P
NMR(CDCl3): d= 22.30; GC–MS m/z (%): 381 (M
, 100).
Anal. Calc. for C19H24NO6P: C, 58.01; H, 6.15; N, 3.56.
Found: C, 58.00; H, 6.13; N, 3.5.2.2.1.6. Dimethyl benzo[d][1,3]dioxol-5-yl(phenylamino)meth-
ylphosphonate (4f). Solid, yield 82%, mp 142–143 C;
IR(KBr): mmax = 3290 (N–H), 1236 (P‚O), 1067 (P–O–C),
750 (P–C) cm1; 1H NMR (500 MHz, CDCl3): d= 7.19–
6.50 (m, 8Ar-H), 6.54 (s, 1H, NH), 5.82 (s, 2H, OCH2O),
4.59 (d, J = 24.9 Hz, 1H, P–CH), 4.15 (d, J = 9.2 Hz, 3H,
P(O)CH3), 4.12 (d, J = 9.0 Hz, 3H, P(O)CH3);
13C NMR
(125 MHz, CDCl3): d= 148.5 (C-5), 146.9 (C-1
1), 145.1
(C-9), 129.2 (C-3), 128.4 (C-31 & C-51), 120.5 (C-41), 120.0
(C-11), 112.8 (C-10), 112.4 (C-21 & C-61), 112.2 (C-4), 102.3
(C-7), 64.3 (d, J= 152.4 Hz,C-2), 53.3 (d, J= 5.6 Hz,
P(O)CH3), 53.2 (d, J= 5.5 Hz, P(O)CH3);
31P NMR(CDCl3):
d= 22.24; GC–MS m/z (%): 335 (M, 100). Anal. Calc. for
C16H18NO5P: C, 57.31; H, 5.41; N, 4.18. Found: C, 57.29;
H, 5.40; N, 4.17.
2.2.1.7. Dimethyl benzo[d][1,3]dioxol-5-yl(4-chlorophenylami-
no)methylphosphonate (4g). Solid, yield 78%, mp 126–127 C;
IR(KBR): mmax = 3340 (N–H), 1234 (P‚O), 1020 (P–O–C),
754 (P–C) cm1; 1H NMR (500 MHz, CDCl3): d= 7.61–
6.40 (m, 7Ar-H), 6.42 (s, 1H, NH), 5.79 (s, 2H, OCH2O),
4.54 (d, J = 24.8 Hz, 1H, P–CH), 4.05 (d, J = 9.8 Hz, 3H,
P(O)CH3), 3.08 (d, J = 9.2 Hz, 3H, P(O)CH3),
13C
NMR(125 MHz, CDCl3): d= 148.2 (C-5), 145.9 (C-1
1),
145.5 (C-9), 128.5 (C-3), 128.9 (C-31 & C-51), 124.5 (C-41),
120.5 (C-11), 112.6 (C-10), 115.5 (C-21 & C-61), 110.2 (C-4),
101.2 (C-7), 65.5 (d, J= 152.2 Hz, C-2), 52.4 (d, J= 6.8 Hz,
P(O)CH3), 52.3 (d, J= 6.2 Hz, P(O)CH3);
31P NMR(CDCl3):
d= 22.22; GC–MS m/z (%): 369 (M, 100). Anal. Calc. for
C16H17ClNO5P: C, 51.98; H, 4.63; N, 3.79. Found: C, 51.96;
H, 4.61; N, 3.78.
2.2.1.8. Dimethyl benzo[d][1,3]dioxol-5-yl(4-bromophenylami-
no)methylphosphonate (4h). Solid, yield 76%, mp 132–133 C;
IR(KBr): mmax = 3294 (N–H), 1236 (P‚O), 1024 (P–O–C),
758 (P–C) cm1; 1H NMR (500 MHz, CDCl3): d= 7.57–
6.39 (m, 7Ar-H), 5.80 (s, 2H, OCH2O), 4.50 (d, J = 25.8 Hz,
1H, P–CH), 4.20 (d, J = 10.2 Hz, 3H, P(O)CH3), 4.10 (d,
J = 9.8 Hz, 3H, P(O)CH3);
13C NMR(125 MHz, CDCl3):
d= 148.4 (C-5), 145.8 (C-9), 145.5 (C-11), 132.2 (C-31 &
C-51), 128.4 (C-3), 120.5 (C-11), 114.9 (C-41), 113.8 (C-21 &
C-61), 113.0 (C-4), 111.9 (C-10), 102.4 (C-7), 65.3
(d, J= 150.8 Hz, C-2), 53.4 (d, J= 7.2 Hz, P(O)CH3), 53.2
(d, J= 6.8 Hz, P(O)CH3);
31P NMR(CDCl3): d= 22.29;
GC–MS m/z (%): 414 (M+, 100). Anal. Calc. for
C16H17BrNO5P: C, 46.40; H, 4.14; N, 3.38. Found: C, 46.39;
H, 4.12; N, 3.36.
2.2.1.9. Dimethylbenzo[d][1,3]dioxol-5-yl(3-chloro-4-ﬂuor-
ophenylamino) methylphosphonate (4i). Solid, yield 76%, mp
122–123 C; IR(KBr): mmax = 3324 (N–H), 1240 (P‚O),
1020 (P–O–C), 758 (P–C) cm1; 1H NMR(500 MHz, CDCl3):
d= 7.81–6.20 (m, 6Ar-H), 6.18 (s, 1H, NH), 5.84 (s, 2H,
OCH2O), 4.58 (d, J = 25.5 Hz, 1H, P–CH), 4.15 (d,
J= 9.2 Hz, 3H, P(O)CH3), 4.10 (d, J = 9.0 Hz, 3H,
P(O)CH3);
13C NMR(125 MHz, CDCl3): d= 148.3 (C-5),
145.9 (C-9), 145.2 (C-41), 143.9 (C-11), 130.1 (C-3), 121.2
(C-31), 120.3 (C-11), 115.0 (C-61), 114.5 (C-21), 113.9 (C-51),
112.5 (C-10), 111.9 (C-4), 101.3 (C-7), 68.2 (d, J= 152.0 Hz,
C-2), 54.3 (d, J= 6.0 Hz, P(O)CH3), 54.2 (d, J= 6.4 Hz,
P(O)CH3);
31P NMR(CDCl3): d= 22.19; GC–MS m/z (%):
Table 1 Antibacterial activity of compounds (4a–j).
Product Zone of inhibition (%)
Escherichia coli Staphylococcus aureus
100 ppm 50 ppm 25 ppm 100 ppm 50 ppm 25 ppm
4a 08 05 02 09 05 01
4b 07 05 03 07 04 02
4c 08 04 – 08 04 –
4d 05 03 01 07 04 –
4e 07 04 – 06 05 –
4f 08 05 03 10 06 02
4g 08 04 – 09 04 01
4h 07 05 – 08 05 02
4i 06 03 – 09 05 –
4j 05 02 – 07 03 –
Penicillina 12 07 – 11 08 –
a Reference compound.
S688 N.B. Reddy et al.387 (M, 100). Anal. Calc. for C16H16ClFNO5P: C, 49.56; H,
4.16; N, 3.61. Found: C, 49.54; H, 4.14; N, 3.60.
2.2.1.10. Dimethylbenzo[d][1,3]dioxol-5-yl(4-methoxyphenyl-
amino)methylphosphonate (4j). Solid, yield 80%, mp 138–
139 C; IR(KBr): mmax = 3321 (N–H), 1248 (P‚O), 1028 (P–
O–C), 753 (P–C)cm1; 1H NMR(500 MHz, CDCl3):
d= 7.56–6.38 (m, 7Ar-H), 6.14 (s, 1H, NH), 5.80 (s, 2H,
OCH2O), 4.60 (d, J = 25.5 Hz, 1H, P–CH), 4.06 (d,
J = 10.3 Hz, 3H, P(O)CH3), 3.93 (d, J = 9.1 Hz, 3H,
P(O)CH3), 2.46 (s, 1H, OCH3);
13C NMR(125 MHz, CDCl3):
d= 150.5 (C-41), 148.2 (C-5), 145.9 (C-9), 135.5 (C-11), 128.5
(C-3), 120.1 (C-11), 115.0 (C-31 & C-51), 114.9 (C-21 & C-61),
112.9 (C-4), 112.0 (C-10), 101.8 (C-7), 68.5 (d, J= 150.8 Hz,
C-2), 55.4 (Ar-OCH3) 53.4 (d, J= 6.2 Hz, P(O)CH3), 53.2
(d, J= 6.0 Hz, P(O)CH3);
31P NMR(CDCl3): d= 22.28;
GC–MS m/z (%): 365 (M, 100). Anal. Calc. for C17H20NO6P:
C, 55.89; H, 5.52; N, 3.83. Found: C, 55.86; H, 5.50; N, 3.81.
2.3. Biological evaluation
2.3.1. Antibacterial activity assay
Antibacterial activity of (4a–j) was assayed against the growth
of Staphylococcus aureus and Escherichia coli following theTable 2 Antifungal activity of compounds (4a–j).
Product Zone of inhibition (%)
Aspergillus niger
100 ppm 50 ppm 25 p
4a 07 05 03
4b 08 05 03
4c 08 06 02
4d 05 03 01
4e 09 04 –
4f 08 06 03
4g 08 04 –
4h 08 04 –
4i 09 05 02
4j 07 03 –
Griseofulvina 11 08 06
a Reference compound.disc-diffusion assay at three concentrations (100, 50,
25 ppm). The inhibition zone was measured from the border
of the disc to the edge of the clear zone. The majority of the
compounds exhibited moderate to good activity against both
the bacteria (Table 1).
2.3.2. Antifungal activity assay
The compounds (4a–j) were screened for their antifungal
activity against Aspergillus niger and Helminthosporium ory-
zae species along with the standard fungicide Griseofulvin
by the disc diffusion method (Benson et al., 1990) at three
different concentrations (100, 50, 25 ppm). The majority of
the compounds exhibited moderate activity against both the
bacteria (Table 2).3. Results and discussion
In our study, the simplest and most typical starting materials
were used in different combinations. In most of the cases, pip-
eranal (1), primary amines (3a–j) such as aniline and its deriv-
atives, para-chloroaniline, para-bromoaniline, 4-ﬂoro3-
choroaniline, para-methoxyaniline and diethyl phosphite/ di-
methyl phosphite (2) were used.Helmenthosphorium oryzae












Table 3 Triton X-100 catalyzed one-pot synthesis of a-aminophosphonates.
Product R1 R Time (min) Yield (%)
a
4a C2H5 50 82
4b C2H5 40 84
4c C2H5 40 83
4d C2H5 50 79
4e C2H5 30 86
4f CH3 60 82
4g CH3 40 78
4h CH3 50 76
4i CH3 50 76
4j CH3 40 80
a Isolated yields.
Table 4 Effect of catalyst concentration on Scheme 1.





Triton X-100 catalyzed synthesis of a-aminophosphonates S689The three components (1, 2, 3a–j) were measured in equi-
molar quantities and the mixtures were allowed to react vig-
orously in aqueous media at 70 C for 30–60 min with
stirring to afford the corresponding a-aminophosphonates.
Several structurally diverse aniline/substituted anilines,
diethyl phosphite and dimethyl phosphite were subjected to
this novel procedure to give the corresponding a-amino
phosphonates in high to excellent yields. The results are sum-
marized in Table 3.
The presence of electron donating groups on aniline gave
the corresponding products in good yields. The wide applica-
bility of the present method is evident from the fact that it is
tolerant toward various functional groups including alkoxy
and halo compounds. Further we studied the role of catalyst
concentration on the model reaction 4e. We have varied the
catalyst concentration to 5, 10, 15, 20 mol%. The result re-
vealed that, when the reaction was carried out in the presenceof 10, 15, 20 mol% of catalyst it gave lower yield of product
even after prolonged reaction time. At the same time when
the concentration of catalyst was 5 mol% we got excellent
yields of product in a short span. Even after increasing the cat-
alyst concentration above 5 mol% the yields of the products
did not improve. So it is established that the 5 mol% of cata-
lyst is sufﬁcient to catalyze and bring it to completion. The re-
sults are listed in Table 4.
All the products were puriﬁed by column chromatography
and were characterized by elemental analysis, 1H NMR, IR,
13C NMR, 31P NMR and mass spectral data.4. Conclusion
In conclusion, TritonX-100 was found to be an efﬁcient catalyst
for the one-pot reaction of aldehyde, amines and diethylphosph-
ite/dimethylphosphite to afford the corresponding a-amino-
phosphonates in moderate to good yields. The main
advantages of the present synthetic protocol are mild reaction,
solvent-free conditions, ecofriendly catalyst and easy work-up
procedure. The derivatives are characterized by physicochemi-
cal and spectral analysis such as 1H NMR, IR, 13C NMR, 31P
NMR and mass spectral data. The spectral data obtained were
in full agreement with the proposed structures. The majority
of the compounds exhibited moderate activity against both
bacteria.
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